# Kamps Rx Genetics – FDA Inspection, Mar 31, 2026

Source: https://www.keypedia.com/records/fda_inspections/kamps-rx-genetics/74d1d37b-36a8-4a38-bce3-87ce8e0505a1
Source feed: FDA_Inspections

> FDA inspection 1310170 of Kamps Rx Genetics, March 31, 2026. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 530. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1310170
- Company Name: Kamps Rx Genetics
- Inspection Date: 2026-03-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Monitoring of Marketed Animal Drugs, Feeds, and Devices
- Product Type: Animal Drugs & Feeds
- Center: Animal Drugs & Feeds
- Office Name: Minneapolis District Office
- Citation Count: 2

## Related Officers

- [Tyson J. Eldridge-Stedman](https://www.keypedia.com/people/tyson-j-eldridge-stedman/544de123-d9c0-4b26-9dc3-420d510c2b4c)

Company: https://www.keypedia.com/companies/kamps-rx-genetics/9c3029b4-7f9a-4c3e-9ab7-f0d8b35409a6

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d